1型糖尿病脑小血管病的临床与MRI特征
本横断面研究纳入191例中位年龄40.0岁的1型糖尿病患者和30名健康对照,评估脑小血管病(SVD)患病率及相关因素。1型糖尿病组任何SVD标志物(35% vs 10%,P=0.005)和脑微出血(24% vs 3.3%,P=0.008)均更常见,脑微出血与收缩压独立相关(OR 1.03 [95% CI 1.00-1.05],P=0.035)。
要点
- 1型糖尿病患者脑小血管病总体患病率35%,显著高于健康对照的10%。
- 脑微出血在1型糖尿病中占24%,显著高于对照的3.3%。
- 收缩压与脑微出血独立相关(OR 1.03 [95% CI 1.00-1.05])。
核心结论
- 1型糖尿病患者脑小血管病,尤其是脑微出血,比健康对照更常见。
研究设计与样本
- 横断面亚研究,纳入191例1型糖尿病患者(中位年龄40.0岁,IQR 33.0-45.1)和30名年龄性别匹配的健康对照。
- 所有参与者接受临床检查及脑MRI评估脑小血管病。
主要发现
- 任何SVD标志物在1型糖尿病组为35%,健康对照为10%(P=0.005)。
- 脑微出血在1型糖尿病组为24%,健康对照为3.3%(P=0.008)。
- 白质高信号在1型糖尿病组为17%,健康对照为6.7%(P=0.182)。
- 腔隙灶在1型糖尿病组为2.1%,健康对照为0%(P=1.000)。
- 脑微出血与收缩压独立相关(OR 1.03 [95% CI 1.00-1.05],P=0.035)。
临床怎么用
- 对年轻1型糖尿病患者应关注脑小血管病,尤其脑微出血的筛查。
- 管理1型糖尿病时需重视收缩压控制,可能与脑微出血风险相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the prevalence of cerebral small-vessel disease (SVD) in subjects with type 1 diabetes compared with healthy control subjects and to characterize the diabetes-related factors associated with SVD. RESEARCH DESIGN AND METHODS: This substudy was cross-sectional in design and included 191 participants with type 1 diabetes and median age 40.0 years (interquartile range 33.0-45.1) and 30 healthy age- and sex-matched control subjects. All participants underwent clinical investigation and brain MRIs, assessed for cerebral SVD. RESULTS: Cerebral SVD was more common in participants with type 1 diabetes than in healthy control subjects: any marker 35% vs. 10% (P = 0.005), cerebral microbleeds (CMBs) 24% vs. 3.3% (P = 0.008), white matter hyperintensities 17% vs. 6.7% (P = 0.182), and lacunes 2.1% vs. 0% (P = 1.000). Presence of CMBs was independently associated with systolic blood pressure (odds ratio 1.03 [95% CI 1.00-1.05], P = 0.035). CONCLUSIONS: Cerebral SVD, CMBs in particular, is more common in young people with type 1 diabetes compared with healthy control subjects.
引用
- Thorn LM, Shams S, Gordin D, et al. Clinical and MRI Features of Cerebral Small-Vessel Disease in Type 1 Diabetes. Diabetes Care. 2018. PMID: 30552131. doi:10.2337/dc18-1302
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。